New Chemical Entities
Oroxcell investigates new molecules with a focus on the treatment of pain. Pain treatment project started in 2006 and, up to date, it has given birth to a set of active principles and a lead which has entered development phase at the beginning of 2009. Research phase owes its success to a competitive staff and a technological advanced platform.
LOroxcell is searching a faithful partner for clinical and non-clinical development phases allowing drug marketing worldwide, the drug’s market being estimates at a billion Euros.